Follow the 쎌바이오텍 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 쎌바이오텍 has published 14 public disclosures. The latest transaction was reported on 9 December 2025 (Purchase). Among the most active insiders: 쎌바이오텍. Every trade is free.
14
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
3 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.